Cartesian Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $298 | $1,100 | $-759 | $387 |
Gross Profit | 298 | 1,100 | -759 | 387 |
EBITDA | -21,811 | -20,733 | -9,480 | -23,897 |
EBIT | -22,400 | -21,889 | -9,966 | -24,183 |
Net Income | 15,886 | -17,710 | -10,253 | -24,183 |
Net Change In Cash | 298 | 1,100 | -759 | 387 |
Free Cash Flow | -20,116 | -24,183 | -7,707 | 7,492 |
Cash | 160,324 | 180,434 | 212,610 | 219,198 |
Basic Shares | 26,447 | 25,902 | 25,907 | 21,471 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $38,913 | $26,004 | $110,777 | $85,077 |
Gross Profit | 38,913 | 24,451 | 108,740 | 85,077 |
EBITDA | -77,137 | -235,064 | 39,838 | -5,158 |
EBIT | -78,288 | -235,907 | 37,801 | -6,877 |
Net Income | -77,424 | -219,710 | 35,379 | -25,687 |
Net Change In Cash | 38,913 | 26,004 | 110,777 | 85,077 |
Cost of Revenue | -7,418 | -24,628 | ||
Free Cash Flow | -32,767 | -51,367 | -32,832 | -61,467 |
Cash | 212,610 | 76,911 | 106,438 | 114,057 |
Basic Shares | 155,110 | 5,170 | 4,052 | 3,175 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.77 |
2025-03-31 | -$0.65 |
2024-12-31 | -$0.59 |
2024-09-30 | -$0.42 |
